ETH Zürich, Institute of Integrative Biology, Zürich, Switzerland.
Nat Genet. 2011 May;43(5):487-9. doi: 10.1038/ng.795. Epub 2011 Mar 27.
The development of a quantitative understanding of viral evolution and the fitness landscape in HIV-1 drug resistance is a formidable challenge given the large number of available drugs and drug resistance mutations. We analyzed a dataset measuring the in vitro fitness of 70,081 virus samples isolated from HIV-1 subtype B infected individuals undergoing routine drug resistance testing. We assayed virus samples for in vitro replicative capacity in the absence of drugs as well as in the presence of 15 individual drugs. We employed a generalized kernel ridge regression to estimate main fitness effects and epistatic interactions of 1,859 single amino acid variants found within the HIV-1 protease and reverse transcriptase sequences. Models including epistatic interactions predict an average of 54.8% of the variance in replicative capacity across the 16 different environments and substantially outperform models based on main fitness effects only. We find that the fitness landscape of HIV-1 protease and reverse transcriptase is characterized by strong epistasis.
鉴于现有大量药物和耐药突变,要定量理解 HIV-1 耐药性中的病毒进化和适应度景观是一项艰巨的挑战。我们分析了一个数据集,该数据集测量了 70081 个从接受常规耐药性检测的 HIV-1 亚型 B 感染者中分离的病毒样本的体外适应性。我们在没有药物和存在 15 种单一药物的情况下检测了病毒样本的体外复制能力。我们采用广义核脊回归来估计 HIV-1 蛋白酶和逆转录酶序列中发现的 1859 个单一氨基酸变异的主要适应度效应和上位性相互作用。包括上位性相互作用的模型可预测在 16 种不同环境中复制能力的平均方差为 54.8%,明显优于仅基于主要适应度效应的模型。我们发现 HIV-1 蛋白酶和逆转录酶的适应度景观的特征是强烈的上位性。